How Wegovy Doses Compare to Mounjaro's Online Prescription
Wegovy Doses vs Mounjaro: Online Prescription Assessment Process
The online prescription process for both Wegovy doses and Mounjaro follows identical clinical pathways at EverydayMeds. Our 3-minute clinical assessment evaluates your medical history, current BMI, contraindications, and weight management goals to determine suitability for either treatment. Licensed UK prescribers review every case individually, considering the different mechanisms of action—Wegovy's semaglutide targets GLP-1 receptors exclusively, whilst Mounjaro's tirzepatide activates both GIP and GLP-1 pathways for dual hormone regulation.
The assessment covers essential safety parameters including previous bariatric surgery, eating disorders, family history of thyroid cancer, and current medications that might interact with either treatment. Your prescriber will determine whether Wegovy's structured 5-dose escalation schedule or Mounjaro's different dosing protocol better suits your clinical profile. Both treatments require prescription-only medicine status and cannot be obtained without proper medical oversight, ensuring your safety throughout the weight management journey.
Wegovy Doses vs Mounjaro: Pricing and Value Comparison
Understanding the cost differences between Wegovy doses and Mounjaro helps inform your treatment decision alongside clinical considerations. Wegovy follows a structured escalation: 0.25mg (£79.99), 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), and 2.4mg maintenance (£209.99). Our Getting Started bundles provide convenient dose progression—the Intro Duo (0.25mg & 0.5mg) costs £169.99, whilst the Progress Trio (0.5mg, 1mg & 1.7mg) is £369.99. New customers apply discount code FIRST40 at checkout, with returning customers using DOSE25.
Mounjaro pricing reflects its different dosing schedule and dual-hormone mechanism, with comparable monthly costs when considering the distinct therapeutic approaches. Both treatments represent significant investments in long-term weight management, requiring ongoing commitment as clinical trials demonstrate weight regain when discontinued. The Ultimate Stability Trio provides three months of Wegovy 2.4mg maintenance supply for £649.99, ensuring consistent treatment without monthly reordering once you've reached your target dose.
Clinical Evidence: Wegovy Doses vs Mounjaro Mechanisms
The clinical evidence supporting Wegovy doses versus Mounjaro reflects their different mechanisms of action rather than direct superiority. Wegovy's semaglutide demonstrated approximately 15% average weight loss at 68 weeks in the STEP 1 trial (Wilding et al., NEJM, 2021), whilst STEP 5 showed sustained 15.2% reduction at 2 years when used alongside a reduced-calorie diet and increased physical activity.
Mounjaro's tirzepatide works through dual GIP and GLP-1 receptor activation, offering a different therapeutic approach to appetite regulation and glucose metabolism. Both treatments require prescription-only medicine status due to their potent effects on hormonal pathways. The choice between Wegovy doses and Mounjaro should consider individual response patterns, tolerability profiles, and specific metabolic needs rather than assuming one approach suits all patients.
How Wegovy Works Compared to Mounjaro's Dual Action
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormone to reduce appetite and promote feelings of fullness after smaller meals. This single-pathway approach targets specific brain regions controlling food intake, potentially reducing cravings and supporting portion control. The medication works by slowing gastric emptying, meaning food stays in your stomach longer, contributing to sustained satiety between meals. Wegovy's mechanism also influences glucose regulation, though its primary licensed indication focuses on weight management in adults with BMI ≥30 or BMI ≥27 with weight-related comorbidities. The treatment must be combined with lifestyle modifications including reduced-calorie diet and increased physical activity to achieve optimal results.
Online Prescription Ordering Process for Both Treatments
Obtaining your prescription for either Wegovy doses or Mounjaro involves identical streamlined steps designed for convenience and clinical safety. Complete our 3-minute online clinical assessment covering medical history, current medications, weight management goals, and contraindications specific to GLP-1 or dual GIP/GLP-1 treatments. Licensed UK prescribers from our GPhC-registered pharmacy (#9012878) review every submission within 3 working days, with express 24-hour review available for urgent requirements. Once approved, your prescription-only medicine ships via next-day cold-chain delivery, maintaining the required 2-8°C temperature throughout transit. The entire process eliminates GP appointments, referral delays, and pharmacy queues whilst maintaining full clinical oversight and safety protocols.
Storage and Practical Differences: Wegovy Doses vs Mounjaro
Storage requirements reveal practical advantages when comparing Wegovy doses versus Mounjaro for busy lifestyles and travel commitments. Wegovy can remain at room temperature below 30°C for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both require refrigerated storage at 2-8°C before first use, with Wegovy supplied in pre-filled FlexTouch pens containing 4 doses each. The dose escalation schedule differs significantly—Wegovy follows mandatory 4-week intervals through 0.25mg, 0.5mg, 1mg, 1.7mg, before reaching 2.4mg maintenance, whilst Mounjaro uses its own distinct escalation protocol. You cannot skip Wegovy doses during escalation, as each stage allows your body to adapt to increasing semaglutide levels whilst minimising gastrointestinal side effects.
Wegovy Doses vs Mounjaro: Personalised Online Prescription Selection
The decision between Wegovy doses and Mounjaro extends beyond simple efficacy comparisons to encompass individual metabolic profiles, lifestyle factors, and treatment preferences. Your online prescription assessment evaluates factors like previous weight loss attempts, medication tolerability, injection frequency preferences, and specific health conditions that might favour one mechanism over another. Some patients respond better to Wegovy's singular GLP-1 pathway, whilst others may benefit from Mounjaro's dual hormone approach.
Our prescribers consider your work schedule, travel requirements, and storage capabilities when recommending between treatments—Wegovy's extended room temperature stability suits frequent travellers, whilst Mounjaro's different dosing intervals might align better with specific routine preferences. Both treatments are available through our online prescription service, ensuring you can access either option based on clinical appropriateness rather than availability constraints that affect traditional healthcare pathways.
Secure Your Wegovy Doses vs Mounjaro Prescription Today
Both Wegovy and Mounjaro remain available through EverydayMeds' streamlined online prescription service, with new customers applying discount code FIRST40 and returning customers using DOSE25 at checkout. Your licensed prescriber will determine which treatment—Wegovy's proven semaglutide approach or Mounjaro's dual-hormone mechanism—aligns with your clinical profile and weight management objectives. Complete your 3-minute assessment at https://everydaymeds.co.uk/collections/wegovy to begin your consultation, with both prescription-only medicines available for next-day delivery once approved. Our clinical team from GPhC-registered pharmacy #9012878 ensures every prescription meets MHRA safety standards whilst providing the convenience and discretion you need for successful long-term weight management. Don't let prescription delays postpone your weight management journey—both proven treatments await your clinical assessment today.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
